These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 11425192)
1. Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro. Hedberg KM; Dellheden B; Wikstrand CJ; Fredman P Glycoconj J; 2000 Oct; 17(10):717-26. PubMed ID: 11425192 [TBL] [Abstract][Full Text] [Related]
2. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines. Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468 [TBL] [Abstract][Full Text] [Related]
3. Recombinant antibodies against ganglioside expressed on tumor cells. Hanai N; Nakamura K; Shitara K Cancer Chemother Pharmacol; 2000; 46 Suppl():S13-7. PubMed ID: 10950141 [TBL] [Abstract][Full Text] [Related]
4. Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line. Bjerkvig R; Engebraaten O; Laerum OD; Fredman P; Svennerholm L; Vrionis FD; Wikstrand CJ; Bigner DD Cancer Res; 1991 Sep; 51(17):4643-8. PubMed ID: 1873810 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies. Ohta S; Igarashi S; Honda A; Sato S; Hanai N Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645 [TBL] [Abstract][Full Text] [Related]
6. Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies. Wikstrand CJ; Fredman P; Svennerholm L; Bigner DD Prog Brain Res; 1994; 101():213-23. PubMed ID: 7518092 [TBL] [Abstract][Full Text] [Related]
7. Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside. Welte K; Miller G; Chapman PB; Yuasa H; Natoli E; Kunicka JE; Cordon-Cardo C; Buhrer C; Old LJ; Houghton AN J Immunol; 1987 Sep; 139(6):1763-71. PubMed ID: 2887619 [TBL] [Abstract][Full Text] [Related]
8. Chimeric anti-ganglioside GM2 antibody with antitumor activity. Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257 [TBL] [Abstract][Full Text] [Related]
9. The glioma-associated gangliosides 3'-isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains. Hedberg KM; Mahesparan R; Read TA; Tysnes BB; Thorsen F; Visted T; Bjerkvig R; Fredman P Neuropathol Appl Neurobiol; 2001 Dec; 27(6):451-64. PubMed ID: 11903928 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody. Dippold WG; Knuth A; Meyer zum Büschenfelde KH Cancer Res; 1984 Feb; 44(2):806-10. PubMed ID: 6362854 [TBL] [Abstract][Full Text] [Related]
11. Ganglioside GD2 in reception and transduction of cell death signal in tumor cells. Doronin II; Vishnyakova PA; Kholodenko IV; Ponomarev ED; Ryazantsev DY; Molotkovskaya IM; Kholodenko RV BMC Cancer; 2014 Apr; 14():295. PubMed ID: 24773917 [TBL] [Abstract][Full Text] [Related]
12. [Spectrum pattern and determination of ganglioside from human primary liver cancer of different origins]. Lin ZY Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):336-8. PubMed ID: 2276322 [TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies. Kusano A; Ohta S; Shitara K; Hanai N Anticancer Res; 1993; 13(6A):2207-12. PubMed ID: 8297135 [TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of a novel monoclonal antibody with high binding affinity to ganglioside GD3. Ohta S; Honda A; Tokutake Y; Yoshida H; Hanai N Cancer Immunol Immunother; 1993; 36(4):260-6. PubMed ID: 8439988 [TBL] [Abstract][Full Text] [Related]
15. Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues. Brezicka T; Bergman B; Olling S; Fredman P Lung Cancer; 2000 Apr; 28(1):29-36. PubMed ID: 10704706 [TBL] [Abstract][Full Text] [Related]
17. Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells. Lloyd KO; Gordon CM; Thampoe IJ; DiBenedetto C Cancer Res; 1992 Sep; 52(18):4948-53. PubMed ID: 1516051 [TBL] [Abstract][Full Text] [Related]
18. Correlation of expression of NCAM and GD3 ganglioside to motile behaviour in neoplastic glia. Gratsa A; Rooprai HK; Rogers JP; Martin KK; Pilkington GJ Anticancer Res; 1997; 17(6B):4111-7. PubMed ID: 9428343 [TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of ganglioside and asialoglycosphingolipid antigens in adult T-cell leukemia cells. Suzuki Y; Hirabayashi Y; Matsumoto N; Kato H; Hidari K; Tsuchiya K; Matsumoto M; Hoshino H; Tozawa H; Miwa M Jpn J Cancer Res; 1987 Oct; 78(10):1112-20. PubMed ID: 2890614 [TBL] [Abstract][Full Text] [Related]
20. Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient. Yamaguchi H; Furukawa K; Fortunato SR; Livingston PO; Lloyd KO; Oettgen HF; Old LJ Proc Natl Acad Sci U S A; 1990 May; 87(9):3333-7. PubMed ID: 2159145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]